Transplantation of Gene Edited Upper Airway Basal Stem Cells - Sriram Vaidyanathan, PhD

Dr. Sriram Vaidyanathan, a postdoctoral scholar at the Porteus lab at Stanford University, presents results from CFRI-funded research on identifying biomaterials that enable the transplantation of gene corrected airway stem cells to treat CF. He presents findings from experiments transplanting upper airway basal stem cells into immunocompromised mice using fibrinogen-based scaffolds. This presentation was part of CFRI's Virtual 35th National CF Education Conference on July 30, 2022.

CFRI's 35th National CF Education Conference was sponsored by Vertex Pharmaceuticals, Genentech, Gilead Sciences, Chiesi USA, AbbVie, and Ionis Pharmaceuticals.